BEAT - BioTelemetry, Inc.
| Previous Close | 61.45 |
| Open | 61.45 |
| Bid | 59.70 x 1000 |
| Ask | 61.95 x 4000 |
| Day's Range | 60.15 - 62.50 |
| 52 Week Range | 23.30 - 62.80 |
| Volume | 517,475 |
| Avg. Volume | 381,156 |
| Market Cap | 1.985B |
| Beta | 1.52 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 |
| Earnings Date | Nov 5, 2018 - Nov 9, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 69.00 |
- InvestorPlace•2 days ago
7 Market-Beating Stocks to Buy to Weather a Trade War
Next week, the trade war with China version 2.0 begins. The U.S. will slap tariffs on $200 billion worth of Chinese goods headed to the U.S. How will this affect which stocks to buy? Well, this has hardly rattled the broad markets — as a matter of fact, that they’re acting as they do when they get any good news. Realistic news that the trade war is having an effect is punished for merely being uttered.
- Zacks•3 days ago
Teladoc Leads Telehealth Thanks to its Virtual Care Solution
Teladoc's (TDOC) vast product portfolio, client base, tie-ups and acquisitions make it a leader in the telehealth industry.
- Simply Wall St.•5 days ago
Is It Time To Consider Buying BioTelemetry Inc (NASDAQ:BEAT)?
BioTelemetry Inc (NASDAQ:BEAT), which is in the healthcare business, and is based in United States, received a lot of attention from a substantial price increase on the NasdaqGS over theRead More...
- Motley Fool•10 days ago
Is This High-Growth Company Key to Apple's Healthcare Strategy?
This little-known company has piled up 24 consecutive quarters of year-over-year revenue growth.
- Zacks•10 days ago
Zacks.com featured highlights include: Malibu Boats, BJ's, Group 1, Paycom and BioTelemetry
Zacks.com featured highlights include: Malibu Boats, BJ's, Group 1, Paycom and BioTelemetry
- Zacks•11 days ago
Bet on These 5 Momentum Stocks Backed by Driehaus Strategy
We have used the Driehaus' "buy high and sell higher" principle to choose the best momentum stocks.
- Zacks•17 days ago
Is BioTelemetry (BEAT) Outperforming Other Medical Stocks This Year?
Is (BEAT) Outperforming Other Medical Stocks This Year?
- Zacks•24 days ago
Medical Services Boom Drives Healthcare: 3 Top Picks
Considering the rising popularity of PBM, CRO and EHR in the U.S. Medical Services industry, these three picks might be money-spinning choices for investors.
- The Wall Street Journal•last month
[$$] ActiveCare Makes Peace With Creditor Group
Inc. doubled the investigative budget for a group of unsecured creditors in its bankruptcy, among the concessions the diabetes-management company made to win court approval of its financing and a process to auction off its assets. A group of unsecured creditors of publicly traded ActiveCare, however, raised a slew of objections to the sales timeline and bankruptcy financing, saying the “rushed” process discouraged bidding and hindered an investigation into past dealings.
- Zacks•last month
Is BioTelemetry (BEAT) Outperforming Other Medical Stocks This Year?
Is (BEAT) Outperforming Other Medical Stocks This Year?
- Zacks•last month
The Zacks Analyst Blog Highlights: Banner, Amazon.com, BJ's, athenahealth and BioTelemetry
The Zacks Analyst Blog Highlights: Banner, Amazon.com, BJ's, athenahealth and BioTelemetry
- The Wall Street Journal•last month
[$$] ActiveCare Creditors Group Wants Sales Process Extended
At the urging of secured lender Partners for Growth, which is providing $800,000 in bankruptcy financing, ActiveCare agreed to sell itself to BioTelemetry, whose Telcare Inc. unit has supplied glucometers and glucose testing strips to ActiveCare. ActiveCare has also borrowed money from BioTelemetry, which is owed a total of almost $4.1 million in the bankruptcy.
- GlobeNewswire•2 months ago
Analysis: Positioning to Benefit within BioTelemetry, Genworth Financial, Power Integrations, Phibro Animal Health, BlackRock, and The ExOne — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Aug. 06, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BioTelemetry, ...
- Zacks•2 months ago
Options Traders Expect Huge Moves in BioTelemetry (BEAT) Stock
BioTelemetry (BEAT) needs investors to pay close attention to the stock based on moves in the options market lately.
- Zacks•2 months ago
Zacks.com featured highlights include: BioTelemetry, Fair Isaac, Comerica and Blue Hills
Zacks.com featured highlights include: BioTelemetry, Fair Isaac, Comerica and Blue Hills
- InvestorPlace•2 months ago
4 Top Stocks to Buy on Blockbuster Earnings Growth
Right from the top brass to research analysts, constant earnings growth enthralls everyone. And why not? If the company doesn’t make money, it won’t stand the test of time. Take a company’s revenues over a given period of time, subtract the cost of production and you will have its earnings!Source: Shutterstock
- Zacks•2 months ago
Top Ranked Momentum Stocks to Buy for July 31st
Top Ranked Momentum Stocks to Buy for July 31st
- Zacks•2 months ago
4 Top Stocks to Buy on Blockbuster Earnings Growth
We shortlist four solid stocks that have striking earnings growth and positive estimate revisions.
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of BEAT earnings conference call or presentation 25-Jul-18 9:00pm GMT
Q2 2018 BioTelemetry Inc Earnings Call
- Motley Fool•2 months ago
Here's Why BioTelemetry Rose as Much as 17.5% Today
The medical-device leader announced second-quarter 2018 earnings.
- Associated Press•2 months ago
BioTelemetry: 2Q Earnings Snapshot
The Malvern, Pennsylvania-based company said it had net income of 29 cents per share. Earnings, adjusted for non-recurring costs, came to 46 cents per share. The results surpassed Wall Street expectations. ...
- GlobeNewswire•2 months ago
BioTelemetry, Inc. Reports Second Quarter 2018 Financial Results
Company Delivers Record Results Raises Full-Year Guidance. MALVERN, Pa., July 25, 2018-- BioTelemetry, Inc., the leading remote and wireless medical technology company focused on the delivery of health ...
- Zacks•2 months ago
Elevate Credit (ELVT) and BioTelemetry (BEAT) Are Aggressive Growth Stocks
A look at two stocks for your aggressive growth stock radar.
- Zacks•2 months ago
NovoCure (NVCR) Catches Eye: Stock Jumps 7.4%
NovoCure (NVCR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
- GlobeNewswire•2 months ago
BioTelemetry, Inc. to Release Second Quarter 2018 Earnings Results on July 25, 2018
MALVERN, Pa., July 17, 2018-- BioTelemetry, Inc. will release its second quarter 2018 earnings on Wednesday, July 25 at 4:00 PM Eastern Time.. The BioTelemetry quarterly conference call will be held at ...
